ENGN
enGene TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
RSI (14)
37.1
Neutral
MACD Hist
-0.02
Bearish
ATR (14)
0.10
Available
Vol Z (20)
-0.27
Normal
RET 20D
-20.8%
Negative
Dist 52W High
-87.2%
Below High
Technical chart
1 YearCandles, moving averages, and volume using the current RankAlpha theme.
As of 2026-10-23
Price
SMA 20
SMA 50
SMA 200
Trend readout
Technical readout
Trend
Downtrend (SMA20 < SMA50 < SMA200)
Momentum
Negative momentum · 20D -20.8% · 60D -12.8%
RSI / MACD
RSI 37.1 (Neutral) · MACD hist -0.02
Volatility
Volatility normal (Z -0.27)
SMA20
1.75
SMA50
1.82
SMA200
4.54
EMA12
1.66
EMA26
1.74
BB Upper
2.05
BB Mid
1.75
BB Lower
1.46
RET 5D
-1.3%
RET 20D
-20.8%
RET 60D
-12.8%
RET 120D
-80.2%
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data

